P548: BEMCENTINIB COMBINED WITH LOW-DOSE CYTARABINE IS EFFICACIOUS AND WELL TOLERATED IN RELAPSED AML PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY. UPDATES FROM THE ONGOING PHASE II T... by S. Loges, M. Heuser, J. Chromik, G. Sutamtewagul, S. Kapp-Schwoerer, M. Crugnola, N. Di Renzo, R. Lemoli, D. Mattei, I. Ben-Batalla, J. Waizenegger, L.-M. Rieckmann, M. Janning, C. D. Imbusch, N. Beumer, D. Micklem, C. Gorcea-Carson, G. Lawson, J. Nautiyal, S. Deharo, W. Fiedler, Y. Alvarado-Valero, B. Gjertsen

Get full text